405 related articles for article (PubMed ID: 16393299)
1. Review article: Drug therapy for non-alcoholic fatty liver disease.
Comar KM; Sterling RK
Aliment Pharmacol Ther; 2006 Jan; 23(2):207-15. PubMed ID: 16393299
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic therapy of non-alcoholic steatohepatitis.
Ratziu V; Zelber-Sagi S
Clin Liver Dis; 2009 Nov; 13(4):667-88. PubMed ID: 19818312
[TBL] [Abstract][Full Text] [Related]
3. Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment.
Bugianesi E; Marzocchi R; Villanova N; Marchesini G
Best Pract Res Clin Gastroenterol; 2004 Dec; 18(6):1105-16. PubMed ID: 15561641
[TBL] [Abstract][Full Text] [Related]
4. [Non-alcoholic steatohepatitis].
Alvarez-Martínez H; Pérez-Campos E
Rev Gastroenterol Mex; 2002; 67(2):118-25. PubMed ID: 12214335
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty liver disease: relationship to insulin sensitivity and oxidative stress. Treatment approaches using vitamin E, magnesium, and betaine.
Patrick L
Altern Med Rev; 2002 Aug; 7(4):276-91. PubMed ID: 12197781
[TBL] [Abstract][Full Text] [Related]
6. Review article: the metabolic syndrome and non-alcoholic fatty liver disease.
Loria P; Lonardo A; Carulli L; Verrone AM; Ricchi M; Lombardini S; Rudilosso A; Ballestri S; Carulli N
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():31-6. PubMed ID: 16225469
[TBL] [Abstract][Full Text] [Related]
7. Therapy for nonalcoholic fatty liver disease.
Moseley RH
J Clin Gastroenterol; 2008 Apr; 42(4):332-5. PubMed ID: 18277910
[No Abstract] [Full Text] [Related]
8. Meta-analysis: insulin sensitizers for the treatment of non-alcoholic steatohepatitis.
Rakoski MO; Singal AG; Rogers MA; Conjeevaram H
Aliment Pharmacol Ther; 2010 Nov; 32(10):1211-21. PubMed ID: 20955440
[TBL] [Abstract][Full Text] [Related]
9. Current Pharmacologic Therapy for Nonalcoholic Fatty Liver Disease.
Ganesh S; Rustgi VK
Clin Liver Dis; 2016 May; 20(2):351-64. PubMed ID: 27063274
[TBL] [Abstract][Full Text] [Related]
10. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Younossi ZM
Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
[TBL] [Abstract][Full Text] [Related]
11. [Fatty liver and raised gamma-GT: it can happen to abstainers, too].
Bischoff A
MMW Fortschr Med; 2002 Feb; 144(7):18. PubMed ID: 11887726
[No Abstract] [Full Text] [Related]
12. Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis.
Idilman R; Mizrak D; Corapcioglu D; Bektas M; Doganay B; Sayki M; Coban S; Erden E; Soykan I; Emral R; Uysal AR; Ozden A
Aliment Pharmacol Ther; 2008 Jul; 28(2):200-8. PubMed ID: 18445142
[TBL] [Abstract][Full Text] [Related]
13. Comparative therapeutic effects of metformin and vitamin E in a model of non-alcoholic steatohepatitis in the young rat.
Raso GM; Esposito E; Iacono A; Pacilio M; Cuzzocrea S; Canani RB; Calignano A; Meli R
Eur J Pharmacol; 2009 Feb; 604(1-3):125-31. PubMed ID: 19135440
[TBL] [Abstract][Full Text] [Related]
14. Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment.
Ersöz G; Günşar F; Karasu Z; Akay S; Batur Y; Akarca US
Turk J Gastroenterol; 2005 Sep; 16(3):124-8. PubMed ID: 16245220
[TBL] [Abstract][Full Text] [Related]
15. Treatment of patients with non-alcoholic fatty liver disease: current views and perspectives.
Federico A; Trappoliere M; Loguercio C
Dig Liver Dis; 2006 Nov; 38(11):789-801. PubMed ID: 16750661
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic fatty liver disease.
Paredes AH; Torres DM; Harrison SA
Clin Liver Dis; 2012 May; 16(2):397-419. PubMed ID: 22541706
[TBL] [Abstract][Full Text] [Related]
17. [Therapeuric aspects of NAFLD. A literature review].
Tapia NC; Avila FI; Leiva JG; Ramos MH; Avila JF; Uribe M
Rev Gastroenterol Mex; 2006; 71(4):487-95. PubMed ID: 17542283
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic options in non-alcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study.
Georgescu EF; Georgescu M
J Gastrointestin Liver Dis; 2007 Mar; 16(1):39-46. PubMed ID: 17410287
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic fatty liver disease: pharmacologic and surgical options.
Parikh N; Ahmad J
Gastroenterol Clin North Am; 2011 Sep; 40(3):541-59. PubMed ID: 21893273
[TBL] [Abstract][Full Text] [Related]
20. Non-alcoholic fatty liver and insulin resistance: a cause-effect relationship?
Bugianesi E; Zannoni C; Vanni E; Marzocchi R; Marchesini G
Dig Liver Dis; 2004 Mar; 36(3):165-73. PubMed ID: 15046183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
